Merit Medical Systems, Inc. vs Merck & Company, Inc. — Stock Comparison
Q·Score Breakdown
7.6
Bullish
Overall
6.7
Neutral
Quality
Health
Growth
Valuation
Sentiment
MMSI
Consensus analyst target of $90.64 is 46% above current price.
MRK
Forward P/E of 11.5× is low relative to sector peers.
Analyst Consensus
BUY
Target $90.64 (+46.2%)
11 analysts
BUY
Target $129.74 (+15.7%)
27 analysts
Fundamentals
MMSI
MRK
26.7×
Trailing P/E
31.5×
14.1×
Forward P/E
11.5×
9.0%
Profit Margin
13.6%
48.7%
Gross Margin
76.6%
9.1%
ROE
—
7.5%
Revenue Growth
4.9%
38.8%
Earnings Growth
—
0.65
Beta
0.28
—
Price / Book
—
$3.7B
Market Cap
$277.0B
$61 – $100
52-Week Range
$73 – $125
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →